Research Analysts’ Recent Ratings Changes for Bed Bath & Beyond (BBBY)

Bed Bath & Beyond (NASDAQ: BBBY) recently received a number of ratings updates from brokerages and research firms:

  • 2/2/2018 – Bed Bath & Beyond was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating.
  • 1/31/2018 – Bed Bath & Beyond was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 1/26/2018 – Bed Bath & Beyond was downgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “underweight” rating. They now have a $18.00 price target on the stock, down previously from $23.03.
  • 1/25/2018 – Bed Bath & Beyond had its “market perform” rating reaffirmed by analysts at Telsey Advisory Group.
  • 1/6/2018 – Bed Bath & Beyond was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 1/4/2018 – Bed Bath & Beyond was given a new $23.00 price target on by analysts at Loop Capital. They now have a “hold” rating on the stock.
  • 12/31/2017 – Bed Bath & Beyond was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating.
  • 12/27/2017 – Bed Bath & Beyond was given a new $23.00 price target on by analysts at Wedbush. They now have a “hold” rating on the stock.
  • 12/27/2017 – Bed Bath & Beyond was given a new $22.00 price target on by analysts at Morgan Stanley. They now have a “sell” rating on the stock.
  • 12/22/2017 – Bed Bath & Beyond was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Bed Bath & Beyond lagged the industry in last three months. Though the company reported top and bottom-line beat in third-quarter fiscal 2017, earnings declined year over year. Sales gained from opportunistic marketing spend and increased promotional offerings as planned for the quarter. However, this led to higher advertising costs and lower margins, which hurt the bottom line. Further, comps declined due to lower average transactions in stores, somewhat mitigated by greater average transaction amount. Additionally, the six-quarter long trend of strained margins due to higher shipping and coupon expenses as well as rise in SG&A, are likely to continue in fiscal 2017. The company also provided a bleak comps and earnings outlook for fiscal 2017. Nonetheless, the company’s transformation plan is on track to deliver a seamless customer experience. Its capital initiatives and constant shareholder-friendly moves also bode well.”
  • 12/22/2017 – Bed Bath & Beyond had its price target lowered by analysts at Jefferies Group LLC to $25.00. They now have an “underperform” rating on the stock.
  • 12/21/2017 – Bed Bath & Beyond had its “sell” rating reaffirmed by analysts at KeyCorp. They now have a $17.00 price target on the stock.
  • 12/21/2017 – Bed Bath & Beyond was given a new $23.00 price target on by analysts at Loop Capital. They now have a “hold” rating on the stock.
  • 12/21/2017 – Bed Bath & Beyond was given a new $25.00 price target on by analysts at Credit Suisse Group AG. They now have a “hold” rating on the stock.
  • 12/21/2017 – Bed Bath & Beyond was given a new $23.00 price target on by analysts at Wedbush. They now have a “hold” rating on the stock.
  • 12/21/2017 – Bed Bath & Beyond was given a new $22.00 price target on by analysts at Morgan Stanley. They now have a “sell” rating on the stock.
  • 12/21/2017 – Bed Bath & Beyond had its price target lowered by analysts at Barclays PLC from $30.00 to $25.00. They now have an “equal weight” rating on the stock.
  • 12/21/2017 – Bed Bath & Beyond was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 12/20/2017 – Bed Bath & Beyond was downgraded by analysts at TheStreet from a “c” rating to a “d+” rating.

Bed Bath & Beyond Inc. (NASDAQ BBBY) opened at $21.76 on Monday. The stock has a market cap of $3,098.90, a PE ratio of 6.25, a PEG ratio of -3.61 and a beta of 1.09. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.67 and a quick ratio of 0.31. Bed Bath & Beyond Inc. has a one year low of $19.07 and a one year high of $41.96.

Bed Bath & Beyond (NASDAQ:BBBY) last issued its earnings results on Wednesday, December 20th. The retailer reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.07. The company had revenue of $2.95 billion for the quarter, compared to analyst estimates of $2.90 billion. Bed Bath & Beyond had a net margin of 4.11% and a return on equity of 19.07%. The company’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.85 EPS. sell-side analysts expect that Bed Bath & Beyond Inc. will post 3.01 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 17th. Investors of record on Friday, March 16th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 2.76%. The ex-dividend date is Thursday, March 15th. Bed Bath & Beyond’s payout ratio is 17.24%.

In related news, VP Matthew Fiorilli sold 16,957 shares of Bed Bath & Beyond stock in a transaction that occurred on Thursday, December 28th. The shares were sold at an average price of $22.62, for a total transaction of $383,567.34. Following the transaction, the vice president now owns 97,419 shares of the company’s stock, valued at approximately $2,203,617.78. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.00% of the stock is owned by company insiders.

Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).

Receive News & Ratings for Bed Bath & Beyond Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply